tirzepatide weight loss efficacy vs semaglutide versus Once Weekly in Patients with Type 2 Diabetes Semaglutide vs Tirzepatide: Effectiveness, Side

Always consult a specialist before combining

Your provider can help determine which option best fits your goals and medical history

Patients taking tirzepatide reached a mean maximum reduction of 14.7% of body weight, or 16.0 kilograms, compared with 10.8%, or 11.6 kilograms, for semaglutide

Weight loss support : People on GLP-1s lose around 811% of body weight after 60 weeks, with some losing more than 20%

Oral semaglutide also demonstrated a favorable cardiovascular safety profile, and significant reductions in cardiovascular death and all-cause mortality vs

Tolerability, adverse reactions, blood pressure, glycemic markers where relevant, and nutritional adequacy all belong in a review, and the pace of any dosage change is a prescriber decision